Franchise opportunities compared

    Amerisourcebergen Drug vs Cait’s Estate Sales

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Initial investment · Item 7

    Amerisourcebergen Drug

    $5,000 – $12,000

    2026 FDD · Item 7 · PDF p. 29

    Cait’s Estate Sales

    $82,455 – $111,383

    2026 FDD · Item 7 · PDF p. 24

    Initial franchise fee · Item 5

    Amerisourcebergen Drug

    Not available

    Cait’s Estate Sales

    $49,900

    2026 FDD · Item 5 · PDF p. 13

    Royalty · Item 6

    Amerisourcebergen Drug

    $599

    2026 FDD · Item 6 · PDF p. 23

    Cait’s Estate Sales

    6.5%; $6,500–$26,000 min

    2026 FDD · Item 6 · PDF p. 14

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Only Cait’s Estate Sales has reviewed Item 19 figures here.

    Financial commitment

    Estimated initial investment (Item 7)

    Amerisourcebergen Drug

    $5,000 – $12,000
    xisting pharmacy with no GNP Private Label product on your shelves we estimate an investment of — 5000
    2026 FDD · Item 7 · PDF p. 29

    Cait’s Estate Sales

    $82,455 – $111,383
    Single-unit total initial investment
    2026 FDD · Item 7 · PDF p. 24
    Standard initial franchise fee (Item 5)

    Amerisourcebergen Drug

    Not available
    No single standard fee identified

    Cait’s Estate Sales

    $49,900
    2026 FDD · Item 5 · PDF p. 13
    Royalty (Item 6)

    Amerisourcebergen Drug

    $599
    ITEM 6 OTHER FEES Type of Fee Amount Due Date Remarks, Definitions and Caveats GNP Premier Fee — 599
    2026 FDD · Item 6 · PDF p. 23

    Cait’s Estate Sales

    6.5%; $6,500–$26,000 min
    Royalty fee
    2026 FDD · Item 6 · PDF p. 14
    Brand / advertising fund (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed brand or advertising fund fee

    Cait’s Estate Sales

    2%
    Brand Development Fund contribution maximum — 2%
    2026 FDD · Item 6 · PDF p. 14

    System scale & health

    Total outlets (Item 20)

    Amerisourcebergen Drug

    2,204
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 55

    Cait’s Estate Sales

    2
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 50
    Net outlet change (Item 20)

    Amerisourcebergen Drug

    −94
    Calculated: 2,298 at end of 2023 → 2,204 at end of 2025

    Cait’s Estate Sales

    +2
    Calculated: 0 at end of 2023 → 2 at end of 2025
    Outlet exits (Item 20)

    Amerisourcebergen Drug

    Not available
    No complete exit records for a year

    Cait’s Estate Sales

    0
    Closures, terminations & non-renewals in 2025 · Calculated turnover 0.0% of outlets at start of year
    2026 FDD · Item 20 · PDF p. 50
    Franchising since (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Cait’s Estate Sales

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Cait’s Estate Sales

    Not available
    Not in reviewed records

    Financial performance (Item 19), by location group

    Amerisourcebergen Drug

    No reviewed Item 19 figures

    Cait’s Estate Sales
    Locations counted not stated in the reviewed record
    $1,289,098
    other Mokena affiliate-owned business gross sales
    2026 FDD · Item 19 · PDF p. 48

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Amerisourcebergen Drug vs Cait’s Estate Sales: common questions

    Which costs less to open, Amerisourcebergen Drug or Cait’s Estate Sales?
    Amerisourcebergen Drug: $5,000 – $12,000 (2026 FDD · Item 7 · PDF p. 29); Cait’s Estate Sales: $82,455 – $111,383 (2026 FDD · Item 7 · PDF p. 24). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for Amerisourcebergen Drug. Estimates are not quotes, and the FDD years may differ.
    How do Amerisourcebergen Drug and Cait’s Estate Sales royalties compare?
    Amerisourcebergen Drug: $599 (2026 FDD · Item 6 · PDF p. 23); Cait’s Estate Sales: 6.5%; $6,500–$26,000 min (2026 FDD · Item 6 · PDF p. 14). Royalties as disclosed in Item 6; other recurring fees are listed separately.
    Which has more locations, Amerisourcebergen Drug or Cait’s Estate Sales?
    Amerisourcebergen Drug: 2,204 (2026 FDD · Item 20 · PDF p. 55); Cait’s Estate Sales: 2 (2026 FDD · Item 20 · PDF p. 50). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
    Do Amerisourcebergen Drug and Cait’s Estate Sales disclose financial performance (Item 19)?
    Amerisourcebergen Drug has no reviewed Item 19 figures on file; Cait’s Estate Sales has reviewed Item 19 figures for 1 location group. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching